Peptide Status Bands: Allowed, Grey, and Not Allowed
A clinic framework for sorting peptide menus into allowed, grey, and not-allowed bands using FDA compounding pages, PCAC context, and pharmacy letters.
PeptIQ Team
Peptide Research & Education
PeptIQ app
Track your peptide protocols in PeptIQ
Log injections, vial supply, and reminders. Use peptiq.io calculators when you need math on the web.
Before marketing, before protocols, before the patient app invite: write one regulatory sentence for every item on the menu. If the sentence needs "FDA reviewed," "moving toward approval," or "clinics everywhere are doing it," rewrite the sentence or drop the compound.
PeptIQ's public status bands tool uses three buckets that match how clinics and counsel already talk: allowed, grey, and not allowed. Signed-in clinics see a finer matrix inside Education → Legal Reference. The public tool is the shareable version.
This is educational, not legal advice.
Band A: Allowed with ordinary prescribing rules
What belongs here: FDA-approved peptide drugs (and other labeled products) filled through ordinary pharmacy channels for labeled or otherwise lawful uses under state scope-of-practice rules.
Examples clinics usually put here first:
Branded GLP-1s such as semaglutide and tirzepatide products when filled as the approved drug
Tesamorelin (Egrifta) for its labeled indication
Other approved peptide drugs with established specialty or retail fills
Clinic test: Can staff name the product, the indication or off-label rationale, and the pharmacy that will fill it?
Does not mean: Off-label use is free of documentation. Medical director and supervision rules still apply in med spa and telehealth settings.
What belongs here: Patient-specific 503A compounding for selected substances, shortage-era GLP-1 compounding questions, favorable PCAC recommendations without final FDA action, and state overlays that change what a pharmacy will put in writing.
Grey does not mean "do whatever." It means "do not proceed on a headline."
Hard requirements in this band:
A pharmacy letter that names the compound and the authority relied on today.
Consent that says the product is compounded and not an FDA-approved finished drug.
Staff language that separates a PCAC recommendation from a final bulks-list decision.
July 2026 context clinics keep getting wrong: PCAC recommended six peptides (including BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon) for the 503A bulks list and recommended against DSIP. FDA staff had advised against the set. That disagreement sits with FDA. It is not overnight authorization. See Category 1 interim access vs waiting and telehealth prescribing after PCAC.
Export the current or proposed menu into a spreadsheet with columns: compound, band, one-sentence status, pharmacy contact, letter on file (Y/N), consent template.
Open the source library and attach a primary URL to each row.
Anything without a letter and a sentence becomes grey at best, not allowed until proven.
Publish only Band A plus the grey items counsel and pharmacy both signed off on.
Med spas that reverse this order (pick viral compounds first, find a vendor second, ask counsel third) are the ones who later say peptides are radioactive.
Where PeptIQ fits
Software does not move a compound between bands. PeptIQ helps after the bands are honest: protocol templates, patient logging, adherence rosters, and (for signed-in clinics) a legality matrix that keeps federal and state overlays in one screen. See the software buyer's guide if that is the next question.
See the provider console
PeptIQ.io for providers is a provider console plus the PeptIQ patient app: protocol templates with phases, patient dose and vial logging, an adherence roster with nudges, staff roles across locations, vial flags, Provider AI, and a revenue forecast from active protocols. It is not an EHR and it does not sell peptides.
This article is educational content from PeptIQ for clinic operators. It is not medical, legal, or regulatory advice. Prescribing, compounding, and consent decisions belong with licensed clinicians, pharmacists, and your counsel. PeptIQ does not sell, source, or dispense peptides.
